In this case, potent activation of Vγ2Vδ2 T cells driven by high-level production of HMBPP in severe tuberculosis may potentially down-regulate IL-22-production and antagonize IL-22-producing T cell-mediated inflammation. Here, IL22 is linked to tuberculosis.